Zymeworks (ZYME) Current Leases (2021 - 2026)
Zymeworks recorded quarterly Current Leases of $3.3 million in Q1 2026, down 5.53% quarter-over-quarter from $3.5 million in Q4 2025, and up 0.64% year-over-year from $3.3 million in Q1 2025.
Zymeworks' Current Leases history runs 6 years deep, the most recent figure standing at $3.3 million for Q1 2026.
- In Q1 2026, Current Leases rose 0.64% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $3.3 million (up 0.64% YoY), while the FY2025 annual figure was $3.5 million, up 26.68% from the prior year.
- Current Leases came in at $3.3 million for Q1 2026 at Zymeworks, down from $3.5 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $4.6 million in Q3 2022 to a low of $2.7 million in Q4 2024.
- A 5-year average of $3.5 million and a median of $3.4 million in 2025 frame the typical range for Current Leases.
- Across the five-year window, Current Leases surged 153.59% in 2022 and plunged 35.7% in 2024, its largest moves.
- Zymeworks' Current Leases stood at $3.3 million in 2022, then gained by 28.27% to $4.3 million in 2023, then tumbled by 35.7% to $2.7 million in 2024, then increased by 26.68% to $3.5 million in 2025, then decreased by 5.53% to $3.3 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $3.3 million, $3.5 million, and $3.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | 3.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.28 Mn |
| Dec 31, 2025 | 3.47 Mn |
| Sep 30, 2025 | 3.40 Mn |
| Jun 30, 2025 | 3.59 Mn |
| Mar 31, 2025 | 3.26 Mn |
| Dec 31, 2024 | 2.74 Mn |
| Sep 30, 2024 | 2.94 Mn |
| Jun 30, 2024 | 2.84 Mn |
| Mar 31, 2024 | 4.16 Mn |
| Dec 31, 2023 | 4.26 Mn |
| Sep 30, 2023 | 3.84 Mn |
| Jun 30, 2023 | 3.65 Mn |
| Mar 31, 2023 | 3.37 Mn |
| Dec 31, 2022 | 3.32 Mn |
| Sep 30, 2022 | 4.61 Mn |
| Dec 31, 2021 | 1.31 Mn |